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Background: Immediate evaluation is possible for the percutaneous 
CT-guided cryosurgery by estimation of Hounsﬁeld units, the size of 
formed ice-ball, and the percentage of tumor area covered by ice-ball. 
But, this method is not useful for the patient underwent ﬂuoroscopy-
guided or video-assisted thoracosopic cryosurgery. And, the majority 
of the lesions are turned into cavitary lesion or necrotic area in the 
early postoperative periods. So, the aim of this study is to identify the 
methods and ideal time for the evaluation of the completeness of cryo-
therapy in an attempt to quantify initial treatment success.
Methods: 52 pulmonary tumors in 34 consecutive patients (29 men and 
5 women, median age 63 years, age range; 25-80 years) were treated by 
cryosurgery. Of the 52 pulmonary masses, 29 masses were primary lung 
cancers, and 23 masses were metastatic lung cancers. Cryosurgery was 
performed under computed tomographic, ﬂuoroscopic or video-assisted 
thoracoscopic guidance. Cryoablation was performed as one or two cy-
cles of 20-minute freeze followed by 5-minute thaw. Follow up chest CT 
scanning was taken at postoperative 1 month, 3 months and 6 months. 
We measured the area and Hounsﬁeld units of the mass with computed 
tomography. And we compare the measured value respectively.
Results: The measured area of the mass is ranged from 141.8mm2 to 
3996.8mm2 preoperatively (postoperative 1 month; 66.8-8481.8mm2, 3 
months; 32.6-4841.7mm2, 6 months; 45.6-4572.2mm2). The Hounsﬁeld 
unit is ranged from 32 to 98 preoperatively (postoperative 1 month; 8-
71, 3 months; 24-68, 6 months; 26-98). And, the decrease of the Houn-
sﬁeld unit of 1 month showed good correlation of the reduction of the 
area of mass at postoperative 6 months (p-value=0.14). On the contrary, 
between the change of the Hounsﬁeld unit and the change of the area of 
mass at 3 months or 6 months showed no correlation statistically.
Conclusion: Postoperative computed tomographic scanning with mea-
surement of Hounsﬁeld unit at postoperative 1 month may be useful 
for the evaluation of the completeness of cryotherapy in an attempt to 
quantify initial treatment success.
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Background: Cryoablation for lung tumors is minimally invasive with 
median hospital stay of 2.6 days after treatment. However, local recur-
rences have occurred in 30% of treated tumors. In the present study, we 
analyzed the potential factors affecting local recurrence.
Materials and Methods: 173 tumors in 63 patients were followed up 
for more than 6 months after cryoablation. In these patients, 3 indices 
were examined. The diameter of tumors, distance between tumor and 
vessels 3 mm or larger, and the extent of the high density area (HDA) 
appearing after treatment which covers the tumor. Follow-up CT scan 
was taken every 3 months after treatment. Accumulated local control 
rate (LCR) was calculated by Kaplan Meier’s method.
Results: 173 tumors included 12 primary lung cancer and 161 meta-
static tumors with median diameter of 16.1mm. LCR 1 year after treat-
ment (1 year LCR) was 92% in 57 tumors of 10 mm or less in diameter, 
71% in 87 tumors of 11-20 mm, and 63% in 14 of 21-30 mm. 6 months 
LCR in 15 tumors of 30 mm or more in diameter was 47%. 1 year LCR 
in 106 tumors of 20 mm or less diameter devoid of large vessels within 
4 mm from the margin of the tumor was 88% and that in 35 tumor of 
20 mm or less with large vessels within 4 mm was 39%, signiﬁcantly 
lower (p<.0001). Among 140 tumors of 20 mm or less diameter with 
measurable HDA on CT scan after treatment, 120 with HDA covering 
whole tumor showed 83% of 1 year LCR and 20 with insufﬁcient HDA 
coverage showed signiﬁcantly lower LCR of 32% (p<.0001). Signiﬁ-
cant correlation between the distance from large vessels and sufﬁcient 
HDA was shown (Fisher’s test; p=.014).
Conclusion: Tumor diameter over 31mm, 4 mm or nearer to large ves-
sels (3 mm or more diameter), and insufﬁcient high density area (not 
covering whole tumor) were poor prognostic factors for crypablation 
against malignant pulmonary tumors.
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Background: Many patients with lung cancer cannot undergo chemo-
therapy or radiation therapy due to impaired pulmonary function or 
poor general performance status. Most of them show resistance to these 
treatments, resulting in continued tumor growth and spreading. In such 
patients, minimally invasive treatments directed to local tumors may 
relieve patients from cancer pain or other generalized symptoms. As 
cryosurgery has been proven to be effective and also safe for cancers 
in prostate, kidneys, liver and endobronchial obstructive tumors, we 
sought to evaluate our results and safety of cryosurgery for lung cancer.
Methods: At our hospital, from October, 2004 to December, 2005, 28 
patients were treated by cryosurgery. The average age of the patients 
was 59.8. Of the 28 patients, 18 had primary lung cancer, and 10 had 
metastatic lung cancers. The average tumor size was 49.9mm. Cryosur-
gery was performed using a cryoprobe under CT guidance using local 
anesthesia. Follow up chest CT scan was taken at post operative day 
on 1 week, 1mo, 3mo and 6 months, and surgical ﬁnal outcome was 
evaluated according to RECIST (complete remission, partial remission, 
stable disease, and progression). 
Results: There were no procedure related mortalities. Postoperative 
pleural effusion was noted in 1 case (3.5%) and there were 9 cases 
(32%) of pneumothorax of which 3 needed closed thoracostomies. 
Small amounts of blood tinged sputum was noted by 15 of the patients 
(53.6%). Of the 28 patients, 3 patients (10.7%) showed complete remis-
sion and six (21.4%) resulted in disease progression. 21 patients (75%) 
of the patients exhibited response to the cryosurgical procedure. 
Conclusions: Cryosurgery for lung cancer can be performed safely 
under local anesthesia, and patients can be discharged early without se-
